The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: AIB adds two to board; Lamprell taps ex-Aramco exec

Tue, 14th Sep 2021 15:02

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

AIB Group PLC - Dublin-based bank - Hires Tanya Horgan and Jan Sijbrand as independent non-executive directors, starting immediately. Horgan, an accountant, was most recently chief risk officer for gambling operator Flutter Entertainment PLC. Sijbrand currently is a member of the Supervisory Board of PricewaterhouseCoopers Nederland. As an executive, he worked at lenders ABN Amro Holding NV, Rabobank Nederland and NIBC Bank NV. He also was chair for Supervision at De Nederlandsche Bank NV, the Dutch central bank.

----------

Lamprell PLC - Sharjah, UAE-based engineer for energy industry - Hires Motassim Al Maashouq as independent non-executive director, starting Tuesday. Al Maashouq retired from Saudi Arabian Oil Co in June of last year. At Aramco, he held senior roles including vice president of New Business Development, VP of Corporate Planning, and group treasurer.

----------

AEX Gold Inc - exploration licences in Greenland, including Nalunaq gold mine - Hires James Gilbertson as vice president for Exploration. Gilbertson, a geologist, was managing director of SRK Exploration and has been a consultant to AEX for the past six years.

----------

Bonhill Group PLC - London-based business-to-business media - Anne Donoghue will resign as non-executive director from September 30, due to a new full-time commitment. Bonhill says a search for a new non-executive director is underway.

----------

Caribbean Investment Holdings Ltd - holding company for banking and corporate services businesses based in Belize - Hires Stewart Howard as non-executive director, starting immediately. Howard is chief executive officer of Waterloo Investment Holdings Ltd and managing director of British Caribbean Bank Ltd.

----------

Bivictrix Therapeutics PLC - Macclesfield, England-based drug development company specialising in cancer treatments - Hires Oliver Schon as vice president of Product Development and Chemistry Manufacturing & Controls. Schon is a cancer researcher who previously worked at GlaxoSmithKline PLC and Agenus Inc.

----------

Trinity Exploration & Production PLC - oil assets in Trinidad and Tobago - Hires Derek Hudson as independent non-executive director, starting immediately. Hudson is a geologist with 30-years experience in the oil and gas industry, including at BG Group and subsequently at BG's acquirer Royal Dutch Shell PLC. He currently is non-executive chair of Scotiabank Trinidad & Tobago Ltd.

----------

Tertiary Minerals PLC - mining projects in Zambia, Europe and the US state of Nevada - Hires Patrick Cullen as managing director, starting immediately. Cullen was CEO at AIM-listed Arkle Resources PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.